Literature DB >> 26021793

Survival and prognostic factors of anaplastic thyroid carcinoma.

I R Paunovic1, S B Sipetic, G V Zoric, A D Diklic, D V Savic, J Marinkovic, V R Zivaljevic.   

Abstract

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is relatively rare and represents one of the most aggressive tumours with poor prognosis, despite therapy. The aim of the study was to analyse demographic and clinical characteristics of ATC patients, and to identify survival rates and prognostic factors.
METHODS: In a retrospective study (1995-2005) ATC was found in 150 patients treated at our institution. Survival was calculated by Kaplan-Meier curve and log-rank test. Potential prognostic factors affecting survival were compared by Cox univariate and multivariate analyses.
RESULTS: Mean survival time was 56 weeks; median survival time was 16 weeks and 1 and 5-year survival were 17% and 8%. More than 10% died during the first month and 50% died up to the fourth month. Multivariate analysis showed that age, goitre and surgery were independent prognostic factors of survival in all ATC patients. Among operated patients, the extent of tumour resection, distant metastasis and multicentricity were independent prognostic risk factors of survival. Postoperative radiotherapy was a protective factor.
CONCLUSIONS: There is still no successful treatment of ATC that can guarantee long term survival. Younger patients with pre-existing goitre, who undergo complete resection of unilocular early stage ATC without distant metastasis and with postoperative external radiotherapy, stand a better chance of long-term survival. Copyright© Acta Chirurgica Belgica.

Entities:  

Mesh:

Year:  2015        PMID: 26021793

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  8 in total

1.  The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.

Authors:  Bo Lin; Haiqing Ma; Maoguang Ma; Zhicheng Zhang; Zicheng Sun; I-Yun Hsieh; Okose Okenwa; Haoyan Guan; Jie Li; Weiming Lv
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.

Authors:  Dmytro Oliinyk; Teresa Augustin; Josefine Rauch; Viktoria Florentine Koehler; Claus Belka; Christine Spitzweg; Lukas Käsmann
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-12       Impact factor: 4.322

3.  Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data.

Authors:  Michael Carlberg; Lena Hedendahl; Mikko Ahonen; Tarmo Koppel; Lennart Hardell
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

4.  Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS.

Authors:  Zhen-Wei Zou; Ting Liu; Yong Li; Peng Chen; Xin Peng; Charlie Ma; Wen-Jie Zhang; Pin-Dong Li
Journal:  Redox Biol       Date:  2018-03-01       Impact factor: 11.799

5.  Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.

Authors:  Oussama ElMokh; Dorothée Ruffieux-Daidié; Matthias A Roelli; Amandine Stooss; Wayne A Phillips; Jürg Gertsch; Matthias S Dettmer; Roch-Philippe Charles
Journal:  Oncotarget       Date:  2017-04-11

6.  Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation.

Authors:  Qingchun Li; Wei Liu; Zhenglin Wang; Cong Wang; Zhilong Ai
Journal:  Int J Oncol       Date:  2021-11-15       Impact factor: 5.650

7.  Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer.

Authors:  Bing-Feng Chu; Yi-Yu Qin; Sheng-Lai Zhang; Zhi-Wei Quan; Ming-Di Zhang; Jian-Wei Bi
Journal:  Chin Med J (Engl)       Date:  2016-07-05       Impact factor: 2.628

Review 8.  Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.

Authors:  Ichiro Abe; Alfred King-Yin Lam
Journal:  Histol Histopathol       Date:  2020-11-10       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.